Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Avacopan may cause unexpected side effects, so early monitoring is important.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

The cat's scabies and pneumonia improved significantly with treatment.

Rapamycin-primed exosomes can significantly boost hair regrowth.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Scalp med(R) effectively and safely improves hair count and thickness in men with androgenetic alopecia.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Compounds from Monascus purpureus showed mild antifungal effects.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Anti-CD19 therapy may help treat SLE and NMOSD.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.